DOCSLIB.ORG

Cancer and Glucose

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cancer and Glucose Cancer and Glucose 1271 High Street, Auburn, CA 95603 • Phone (530) 823-7092 • order line (800) 359-6091 Hours: Tues. – Fri. 10 a.m. – 4 p.m. • E-mail: [email protected] web: www.ImageAwareness.com June 2017 Volume 13: Issue 2 Introduction Afterwards, it is believed, he feared causes of cancer. He said, “Cancer, the development of cancer. This prob- above all other diseases, has countless Louis Pasteur observed two types ably saved Warburg’s life. He was the seconday causes. Almost anything of energy production in the world of most prominent cancer researcher in can cause cancer, but even for cancer, single cells. The most primitive form Germany during the Second World there is only one prime cause. The of energy production is anaerobic and War. Hitler turned a blind eye to his prime cause of cancer is the replace- does not use oxygen. This process is Jewish ancestry and ordered him to ment of oxygen in normal body cells also called fermentation and is utilized continue his research on cancer. by fermentation of sugar.” in manufacture of beer and wine. This is considered a more primitive form In 1944, Warburg was nominated Reference: of energy production. for a second Nobel Prize by Albert https://en.wikipedia.org/wiki/Otto_Heinrich_ Szent-Gyorgyi, the scientist who iso- Warburg The second form of energy produc- http://www.nobelprize.org/nobel_prizes/medi- lated vitamin C, for his discovery of tion noted by Pasteur is aerobic which cine/laureates/1931/warburg-bio.html the involvement of nicotinamide (vi- means that it utilized oxygen. This Christofferson, Travis, Tripping Over the Truth, tamin B3) and flavin in fermentation. North Charleston, SC: CreateSpace Independent process is also called respiration. It is Flavin is a yellow pigment found in Publishing Platform, 2014, 32. the form of energy production used by enzymes and vitamin B2. Hitler for- https://commons.wikimedia.org/wiki/DNA#/ most multicellular organisms. media/File:Dna-split.png bade Germans from accepting Nobel Otto Warburg Prizes in 1937. Warburg showed that normal body The DNA Hypothesis Otto Warburg greatly admired cells turned to cancer cells when they Louis Pasteur. He became convinced Percivall Pott was the first scientist are deprived of oxygen for even a few that a defect in energy metabolism to show that cancer could be caused hours time. There was no need to in- was central to the development of by an environmental carcinogen. In troduce carcinogens, radiation, or vi- cancer. He believed this because of 1775 Pott associated chimney soot as ruses to achieve this transformation. the nonspecific nature of the disease. a direct contact carcinogen leading This led Warburg to conclude and to scrotal cancer in chimney sweeps. Warburg won a Nobel Prize in promote the idea that the creation of The primary carcinogen in chimney 1931 for his discoveries relating to cancer cells was due to a defect in cel- soot is also a prime energy production in cells. One of his lular energy metabolism which later suspect in various observations was that cancerous cells came to be identified with the mito- cancers caused by can live and develop in the absence of chondria or energy factories of the smoking cigarettes. oxygen. Today the ability of cancer cells. Pott’s work result- cells to ferment glucose even in the Warburg never gave up his convic- ed in the Chimney presence of oxygen is known as “the tion that the primary cause of cancer Sweepers Act of Warburg effect.” was alterations in glucose metabolism 1788 which sought Warburg had a Jewish father and and energy production. In 1966 at age to reduce the risk lived in Germany throughout the Sec- 82 near the end of his life Warburg of cancer among ond World War. In 1935 Hitler had a summarized his belief about cancer as the young boys polyp removed from his vocal cords. he discussed primary and secondary who were working Copyright © 2017 by Jim McAfee. All rights reserved. 1 specific. the voracious appetite of cancer cells fir glucose. Warburg Continues Hexokinase II binds with a protein Pete Pedersen of Johns Hopkins called VDAC preventing suicide of worked in a laboratory run by Albert cancer cells (apoptosis) and making Lehninger. Leninger had discovered cancer cells immortal. Hexokinase II that mitochondria were the site of also positions itself in the cell in such the cells’ energy production. He also a way that it can steal ATP (the energy as chimney sweeps. knew Warburg personally. Like a dog produced by the cell). In 1966 Francis Peyton Rous was after a stick, Pedersen became fixated In 1991 a brilliant South Korean awarded a Nobel Prize for his work on the metabolism of cancer cells. He scientist, Young Hee Ko, came to showing that viruses could cause found that the cancers that grew the work in Pedersen’s laboratory. She cancer. In 1911 a woman walked fastest and were most aggressive had discovered that a molecule called 3BP into the Rockefeller Institute in New a smaller number of mitochondria and (3-bromopyruvate) could enter the York City carrying a chicken with a fermented more glucose. Tumor cells cell and mortally damage hexokinase large tumor on its breast. Rous surgi- that grew the fastest invariably had II. Ko demonstrated that this com- cally removed the tumor, sliced it into about half the mitochondria of normal pound was much more effective than pieces and placed it into the bodies of body cells. traditional chemotherapeutic agents at other chickens which subsequently Mitochondria of cancer cells were killing cancer cells in virtually every developed cancer. Later Rous filtered also abnormal in structure. They were type of cancer cell tested. Over 100 out bacteria and cancer cells showing missing important internal mem- tissue studies demonstrated the ef- that viruses were causing the cancers. branes and had abnormal protein and fectiveness of the compound against In 1953 James Watson and Fran- lipid content. Pedersen has discovered cis Crick discovered the structure why the Warburg effect takes place. of DNA. It became obvious that the In 1977 Pedersen and a graduate stu- DNA stored information. The scien- dent, Ernesto Bustamante, identified tific community moved away from a chemical messenger, mitochondrial Warburg’s focus on the mitochondrial hexokinase, responsible for pushing origin of cancer and concluded that cells into utilization of fermentation defects in the DNA caused by chemi- for energy production. cal carcinogens, viral infection, or ra- Hexokinase exists in four differ- dioactivity. ent forms (isozymes). The cancer cell It did not take long to trace the produces vastly more hexokinase II, cancer-causing virus Rous had found normally present in only tiny quanti- in chickens to a defect in a specific ties in the normal cells of the body. gene triggered by the virus. It was This form of the enzyme forces glu- named src for sarcoma. This gene was cose down the fermentation pathway found to regulate kinases, key signal- and ignores the regulatory signals of ing molecules in the cell. The viral the cell to slow down. version of the src gene was stuck in The fact that cancer cells stuff the on position causing cells to divide themselves with glucose due to high over and over again. Science began a levels of hexokinase II became the ba- largely fruitless search of DNA for the sis for the PET scan, one of the most cause of cancer. accurate means of identifying where The association of cancer with cancer tumors exist in the body. A DNA led to chemotherapeutic treat- glucose molecule is combined with a ments targeted at preventing replica- fluoride molecule. This “tagged glu- tion of DNA. These treatments kill cose” (FDG or gluorodeoxyglucose) cancer cells, but they also have a can be easily detected by the PET devastating effect on healthy cells. scan. The PET scan is utilized in vir- In other words, the treatments are not tually every cancer center in the world and provides powerful illustration of Copyright © 2017 by Jim McAfee. All rights reserved. 2 Evans, Josie M., et al., Metformin and reduced as a Metabolic Disease. It this book risk of cancer in diabetic patients, BMJ, June 4, 2005,330:1304-1305. he argues that epigenetic signaling https://en.wikipedia.org/wiki/Percivall_Pott travels from damaged mitochondria https://en.wikipedia.org/wiki/Chimney_Sweep- to the nucleus of the cell altering the ers_Act_1788 expression of the genes which have https://commons.wikimedia.org/ the potential to cause cancer. This sig- wiki/Category:Mitochondria#/media/ File:Blausen_0644_Mitochondria.png naling by the mitochondria is called By Kuebi = Armin Kübelbeck - Own work, CC the “retrograde response.” BY-SA 3.0, https://commons.wikimedia.org/w/in- The signals from the damaged mi- dex.php?curid=17398088 tochondria alter the energy production cancer cells. https://commons.wikimedia.org/wiki/ Ko then tested the compound on File:Ketogenic_diets_pie.png of the cell from aerobic metabolism to rabbits. The compound killed cancer fermentation of glucose as a source of cells in living rabbits without killing Caloric Restriction energy for the cell. the animals. Rat studies produced Caloric restriction and fasting In other words, the mitochondria similar results. have been repeatedly shown to reduce are sending a message to the DNA of Ko also was able to sucessfully the risk of cancer and retard cancer the cell: “We cannot produce energy treat one human subject with her growth in both animals and humans. in a normal way and need to alter the compound. At this point the promis- These practices promote improved functioning of this cell to ferment glu- ing new compound became tied up in energy production and rejuvenation cose.
Load more

Recommended publications
  • 書 名 等 発行年 出版社 受賞年 備考 N1 Ueber Das Zustandekommen Der
    書 名 等 発行年 出版社 受賞年 備考 Ueber das Zustandekommen der Diphtherie-immunitat und der Tetanus-Immunitat bei thieren / Emil Adolf N1 1890 Georg thieme 1901 von Behring N2 Diphtherie und tetanus immunitaet / Emil Adolf von Behring und Kitasato 19-- [Akitomo Matsuki] 1901 Malarial fever its cause, prevention and treatment containing full details for the use of travellers, University press of N3 1902 1902 sportsmen, soldiers, and residents in malarious places / by Ronald Ross liverpool Ueber die Anwendung von concentrirten chemischen Lichtstrahlen in der Medicin / von Prof. Dr. Niels N4 1899 F.C.W.Vogel 1903 Ryberg Finsen Mit 4 Abbildungen und 2 Tafeln Twenty-five years of objective study of the higher nervous activity (behaviour) of animals / Ivan N5 Petrovitch Pavlov ; translated and edited by W. Horsley Gantt ; with the collaboration of G. Volborth ; and c1928 International Publishing 1904 an introduction by Walter B. Cannon Conditioned reflexes : an investigation of the physiological activity of the cerebral cortex / by Ivan Oxford University N6 1927 1904 Petrovitch Pavlov ; translated and edited by G.V. Anrep Press N7 Die Ätiologie und die Bekämpfung der Tuberkulose / Robert Koch ; eingeleitet von M. Kirchner 1912 J.A.Barth 1905 N8 Neue Darstellung vom histologischen Bau des Centralnervensystems / von Santiago Ramón y Cajal 1893 Veit 1906 Traité des fiévres palustres : avec la description des microbes du paludisme / par Charles Louis Alphonse N9 1884 Octave Doin 1907 Laveran N10 Embryologie des Scorpions / von Ilya Ilyich Mechnikov 1870 Wilhelm Engelmann 1908 Immunität bei Infektionskrankheiten / Ilya Ilyich Mechnikov ; einzig autorisierte übersetzung von Julius N11 1902 Gustav Fischer 1908 Meyer Die experimentelle Chemotherapie der Spirillosen : Syphilis, Rückfallfieber, Hühnerspirillose, Frambösie / N12 1910 J.Springer 1908 von Paul Ehrlich und S.
    [Show full text]
  • The Use of Non-Human Primates in Research in Primates Non-Human of Use The
    The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations.
    [Show full text]
  • JUAN MANUEL 2016 NOBEL PEACE PRIZE RECIPIENT Culture Friendship Justice
    Friendship Volume 135, № 1 Character Culture JUAN MANUEL SANTOS 2016 NOBEL PEACE PRIZE RECIPIENT Justice LETTER FROM THE PRESIDENT Dear Brothers, It is an honor and a privilege as your president to have the challenges us and, perhaps, makes us question our own opportunity to share my message with you in each edition strongly held beliefs. But it also serves to open our minds of the Quarterly. I generally try to align my comments and our hearts to our fellow neighbor. It has to start with specific items highlighted in each publication. This with a desire to listen, to understand, and to be tolerant time, however, I want to return to the theme “living our of different points of view and a desire to be reasonable, Principles,” which I touched upon in a previous article. As patient and respectful.” you may recall, I attempted to outline and describe how Kelly concludes that it is the diversity of Southwest’s utilization of the Four Founding Principles could help people and “treating others like you would want to be undergraduates make good decisions and build better treated” that has made the organization successful. In a men. It occurred to me that the application of our values similar way, Stephen Covey’s widely read “Seven Habits of to undergraduates only is too limiting. These Principles are Highly Effective People” takes a “values-based” approach to indeed critical for each of us at this particularly turbulent organizational success. time in our society. For DU to be a successful organization, we too, must As I was flying back recently from the Delta Upsilon be able to work effectively with our varied constituents: International Fraternity Board of Directors meeting in undergraduates, parents, alumni, higher education Arizona, I glanced through the February 2017 edition professionals, etc.
    [Show full text]
  • Revistasinvestigacion.Unmsm.Edu.Pe/Index.Php/Rpb/Index © Los Autores
    Memorias del Primer Congreso Internacional de Revista peruana de biología 27(1): 005 - 014 (2020) doi: http://dx.doi.org/10.15381/rpb.v27i1.17624 Biotecnología e innovación - ICBi 2018 ISSN-L 1561-0837; eISSN: 1727-9933 Universidad Nacional Mayor de San Marcos Meeting Report of the First International Congress of Biotechnology and innovation - ICBi 2018 Trabajos presentados al I Congreso Internacional de Biotecnología e innovación (ICBi), 9 - 12 de julio de 2018, Universidad Nacional Agraria La Molina, Lima, Perú. The First International Congress of Biotechnology and Innovation, Editoras: Ilanit Samolski held in Lima- Peru from July 9 to 12, 2018, was organized by the La- Maria Lucila Hernández-Macedo boratory of Mycology and Biotechnology “Marcel Gutiérrez-Correa” Gretty Katherina Villena (LMB-MGC) of La Molina National Agrarian University (UNALM). Organizing Committee Autores President: Gretty K. Villena, Ph.D. in Biological Sciences and Gretty K. Villena * Engineering, https://orcid.org/0000-0001-8123-3559 [email protected] https://orcid.org/0000-0001-8123-3559 Vice-President: Ilanit Samolski, Ph.D. in Biotechnology, Maria Lucila Hernández- Macedo https://orcid.org/0000-0002-1883-7795 [email protected] https://orcid.org/0000-0003-1050-9807 Secretary: Maria Lucila Hernández Macedo, Ph.D. in Cellular Ilanit Samolski and Structural Biology, https://orcid.org/0000-0003-1050- [email protected] 9807 https://orcid.org/0000-0002-1883-7795 Correspondencia Scientific Committee *Corresponding author Universidad Nacional Agraria La Molina *President, ICBi 2018 Laboratorio de Micología y Biotecnología "Marcel Ana Kitazono Sugahara, Ph.D. in Pharmaceutical Sciences and Gutiérrez-Correa" (LMB-MGC), Facultad de Ciencias, Biotechnology, https://orcid.org/0000-0002-6924-1799 Universidad Nacional Agraria La Molina, Lima 12, Perú.
    [Show full text]
  • Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Hollingsworth, Joseph Rogers Working Paper Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research WZB Discussion Paper, No. P 02-003 Provided in Cooperation with: WZB Berlin Social Science Center Suggested Citation: Hollingsworth, Joseph Rogers (2002) : Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research, WZB Discussion Paper, No. P 02-003, Wissenschaftszentrum Berlin für Sozialforschung (WZB), Berlin This Version is available at: http://hdl.handle.net/10419/50229 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence. www.econstor.eu P 02 – 003 RESEARCH ORGANIZATIONS AND MAJOR DISCOVERIES IN TWENTIETH-CENTURY SCIENCE: A CASE STUDY OF EXCELLENCE IN BIOMEDICAL RESEARCH J.
    [Show full text]
  • Virus and Cancer: a Controversial Theory
    CONTRIBUTIONS to SCIENCE, 1 (1): 87-98 (1999) Institut d’Estudis Catalans, Barcelona Francesc Duran Reynals (Barcelona, 1899-New Haven, USA, 1958) Virus and cancer: a controversial theory Thomas F. Glick1* and Antoni Roca Rosell2* 1 Department of History, Boston University, USA 2 Centre de Recerca d’Història de la Tècnica, ETSEIB-UPC, Barcelona Francesc Duran Reynals was most likely the first Catalan to had been rector of the University of Barcelona and, for a few become a research scientist of world renown [1]. months, minister of justice of the Spanish government, pre- Around 1900 both science and technology were well rep- cisely during the year in which Francesc was born. As for his resented in Catalan society. But those with the highest pro- mother, Agnès Reynals i Maillol, she was a daughter of files were the applied fields, such as industrial technology, Estanislau Reynals i Rabassa (1822-1876), also a jurist and medicine, or surgery. The weak initiatives of the Spanish an important protagonist of the political organization of state in this area (demonstrated in, for example, a very small Catalan conservatism and of economic protectionism. university with no outlets for research) practically prevented Francesc’s father, Manuel, died prematurely in 1906, just af- the existence of any relevant academic world [2]. At the na- ter the death, equally premature, of his wife. Their five sons tional level science and higher education policy were cen- –of whom Francesc was the youngest-were placed in the tered on the University of Madrid, but in the first decades of care of their mother’s three sisters, Paulita, Pilar and Anna the century the establishment of research centers was in fact Reynals, and their niece, Paulita Farriols i Reynals, who considered.
    [Show full text]
  • Isolated Mouse Liver Mitochondria Are Devoid of Glucokinase
    BBRC Biochemical and Biophysical Research Communications 334 (2005) 907–910 www.elsevier.com/locate/ybbrc Isolated mouse liver mitochondria are devoid of glucokinase Ernesto Bustamante, Peter Pediaditakis, Lihua He, John J. Lemasters * Department of Cell and Developmental Biology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599-7090, USA Received 21 June 2005 Available online 12 July 2005 Abstract Glucokinase is a hexokinase isoform with low affinity for glucose that has previously been identified as a cytosolic enzyme. A recent report claims that glucokinase physically associates with liver mitochondria to form a multi-protein complex that may be physiologically important in apoptotic signaling [N.N. Danial, C.F. Gramm, L. Scorrano, C.Y. Zhang, S. Krauss, A.M. Ranger, S.R. Datta, M.E. Greenberg, L.J. Licklider, B.B. Lowell, S.P. Gygi, S.J. Korsmeyer, Nature 424 (2003) 952–956]. Here, we re-ex- amined the association of glucokinase with isolated mouse liver mitochondria. When glucokinase activity was measured by coupled enzyme assay, robust activity was present in whole liver homogenates and their 9500g supernatants (cytosol), but activity in the purified mitochondrial fraction was below detection (<0.2% of homogenate). Furthermore, addition of 45 mM glucose in the pres- ence of ATP did not increase mitochondrial respiration, indicating the absence of ADP formation by glucokinase or any other hexo- kinase isoform. Immunoblots of liver homogenates and cytosol revealed strong glucokinase bands, but no immunoreactivity was detected in mitochondria. In conclusion, mouse liver mitochondria lack measurable glucokinase. Thus, functional linkage of gluco- kinase to mitochondrial metabolism and apoptotic signaling is unlikely to be mediated by the physical association of glucokinase with mitochondria.
    [Show full text]
  • Nobel Laureates in Physiology Or Medicine
    All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R.
    [Show full text]
  • Ssfaoggi 201306
    SOCIETA’ DI SCIENZE FARMACOLOGICHE APPLICATE SOCIETY FOR APPLIED PHARMACOLOGICAL SSFAoggi SCIENCES Notiziario di Medicina Farmaceutica Giugno 2013 Bimestrale della Società di Scienze Farmacologiche Applicate Fondata nel 1964 numero 37 Dove sono i nuovi antibiotici? Sommario: La comunità mondiale sta correndo un grosso rischio: questo ci ricordano due editoriali, Editoriale 1 pubblicati su The Lancet e sul British Medical Journal, che riportiamo alle pagine 21 e 22. La resistenza agli antibiotici è un grave problema: The Lancet ci ricorda che fu addirittura Novità in Farmacovigilanza messa in evidenza dallo stesso Alexander Fleming nel 1945, il quale temeva che l’abuso Parte prima 2 della penicillina potesse selezionare ceppi resistenti. Il British Medical Journal evidenzia che molte pratiche mediche e chirurgiche (dall’uso Novità in Farmacovigilanza della chemioterapia agli interventi invasivi in ortopedia e cardiochirurgia) sono possibili Parte seconda 4 grazie alla profilassi con antibiotici. E quindi, la resistenza agli antibiotici non è un solo un problema degli infettivologi, ma sta diventando un problema dei chirurghi, degli oncologi, e Il Decreto Balduzzi 6 di tutto il sistema sanitario. Alcune previsioni sono drammatiche: l’intervento di protesi dell’anca, che è diventato una Farmaci a brevetto scaduto 12 routine per la popolazione anziana, potrebbe essere colpito in modo significativo da com- plicanze infettive, passando dall’1% dei pazienti di oggi fino al 40%-50% dei pazienti nel Affari Istituzionali 12 prossimo futuro, con oltre un terzo di essi in pericolo di vita. Uno scenario davvero preoc- 5a Edizione Master Bicocca 13 cupante. Di fronte a queste previsioni, che ci vengono ormai ripetute ad intervalli regolari, stupisce Master Bicocca 2013: i numeri 13 la mancanza di incentivi per la ricerca di nuovi antibiotici.
    [Show full text]
  • Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research Hollingsworth, J
    www.ssoar.info Research organizations and major discoveries in twentieth-century science: a case study of excellence in biomedical research Hollingsworth, J. Rogers Veröffentlichungsversion / Published Version Arbeitspapier / working paper Zur Verfügung gestellt in Kooperation mit / provided in cooperation with: SSG Sozialwissenschaften, USB Köln Empfohlene Zitierung / Suggested Citation: Hollingsworth, J. R. (2002). Research organizations and major discoveries in twentieth-century science: a case study of excellence in biomedical research. (Papers / Wissenschaftszentrum Berlin für Sozialforschung, 02-003). Berlin: Wissenschaftszentrum Berlin für Sozialforschung gGmbH. https://nbn-resolving.org/urn:nbn:de:0168-ssoar-112976 Nutzungsbedingungen: Terms of use: Dieser Text wird unter einer Deposit-Lizenz (Keine This document is made available under Deposit Licence (No Weiterverbreitung - keine Bearbeitung) zur Verfügung gestellt. Redistribution - no modifications). We grant a non-exclusive, non- Gewährt wird ein nicht exklusives, nicht übertragbares, transferable, individual and limited right to using this document. persönliches und beschränktes Recht auf Nutzung dieses This document is solely intended for your personal, non- Dokuments. Dieses Dokument ist ausschließlich für commercial use. All of the copies of this documents must retain den persönlichen, nicht-kommerziellen Gebrauch bestimmt. all copyright information and other information regarding legal Auf sämtlichen Kopien dieses Dokuments müssen alle protection. You are not allowed
    [Show full text]
  • Laureatai Pagal Atradimų Sritis
    1 Nobelio premijų laureatai pagal atradimų sritis Toliau šioje knygoje Nobelio fiziologijos ir medicinos premijos laureatai suskirstyti pagal jų atradimus tam tikrose fiziologijos ir medicinos srityse. Vienas laureatas gali būti įrašytas keliose srityse. Akies fiziologija 1911 m. Švedų oftalmologas Allvar Gullstrand – už akies lęšiuko laužiamosios gebos tyrimus. 1967 m. Suomių ir švedų neurofiziologas Ragnar Arthur Granit, amerikiečių fiziologai Haldan Keffer Hartline ir George Wald – už akyse vykstančių pirminių fiziologinių ir cheminių procesų atradimą. Antibakteriniai vaistai 1945 m. Škotų mikrobiologas seras Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas seras Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. Audiologija 1961 m. Vengrų biofizikas Georg von Békésy – už sraigės fizinio dirginimo mechanizmo atradimą. Bakteriologija 1901 m. Vokiečių fiziologas Emil Adolf von Behring – už serumų terapijos darbus, ypač pritaikius juos difterijai gydyti (difterijos antitoksino sukūrimą). 1905 m. Vokiečių bakteriologas Heinrich Hermann Robert Koch – už tuberkuliozės tyrimus ir atradimus. 1928 m. Prancūzų bakteriologas Charles Jules Henri Nicolle – už šiltinės tyrimus. 1939 m. Vokiečių bakteriologas Gerhard Johannes Paul Domagk – už prontozilio antibakterinio veikimo atradimą. 1945 m. Škotų mikrobiologas Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. 2005 m. 2 Australų mikrobiologas Barry James Marshall ir australų patologas John Robin Warren – už bakterijos Helicobacter pylori atradimą ir jos įtakos skrandžio ir dvylikapirštės žarnos opos atsivėrimui nustatymą.
    [Show full text]
  • (ARC) Is Expressed in Cancer Cells and Localizes to Nuclei
    FEBS 29471 FEBS Letters 579 (2005) 2411–2415 Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei Mi Wanga, Suparna Qanungoa, Michael T. Crowb, Michiko Watanabec, Anna-Liisa Nieminena,* a Department of Anatomy and Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA b Division of Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University, Baltimore, MD 21224, USA c Department of Pediatrics, Rainbow Babies and ChildrenÕs Hospital, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA Received 14 February 2005; accepted 2 March 2005 Available online 29 March 2005 Edited by Veli-Pekka Lehto and Bax regulate inhibition of apoptosis in a CARD depen- Abstract Apoptosis repressor with caspase recruitment domain is expressed at high levels in brain and myogenic tissues, consis- dent manner [2,6,7]. Therefore, ARC inhibits both extrinsic tent with a role to inhibit apoptosis in the terminally differenti- and intrinsic cell death pathways. Basal levels of ARC in ated cells. Expression of ARC in cancers is not known. In this cardiomyocytes, neurons, and skeletal muscle fibers serve to study, we reported that ARC was highly expressed in various repress apoptosis in these terminally differentiated cells. non-myogenic and non-neurogenic human and rat cancer cell Knockdown of endogenous ARC facilitates death-inducing lines. Unexpectedly, ARC was localized almost exclusively to signaling complex assembly and triggers spontaneous Bax acti- the nuclei of cancer cells, which was unlike the cytoplasmic local- vation and apoptosis [6]. Expression of ARC in cancer cells ization of ARC in non-cancer cells.
    [Show full text]